Fuente: Cruz Martín del Campo SL, Rivera García MT. Las nuevas drogas: origen, mecanismos de acción y efectos. Una revisión de la literatura. RIIAD [Internet]. 1ene.2015 Resumen Introducción: existen en el mercado sustancias psicoactivas de reciente aparición que se conocen genéricamente como nuevas...

Source: Tai, B., Dobbins, R., Blackeney, Q. et al. The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic. Addict Sci Clin Pract 16, 28 (2021). https://doi.org/10.1186/s13722-021-00238-6 Abstract Over the past two decades, the National Drug Abuse Treatment Clinical...

Source: Wen X, Belviso N, Murray E, Lewkowitz AK, Ward KE, Meador KJ. Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital Malformations. JAMA Netw Open. 2021;4(4):e215708. doi:10.1001/jamanetworkopen.2021.5708 Key Points Question Is there an association between prenatal...

Source: Ford, B. R., Bart, G., Grahan, B., Shearer, R. D., & Winkelman, T. N. (2020). Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder. Journal of Addiction Medicine. Abstract Objective: To examine...

Source: Warren EC, Kolodny A. Trends in Heroin Treatment Admissions in the United States by Race, Sex, and Age. JAMA Netw Open. 2021;4(2):e2036640. doi:10.1001/jamanetworkopen.2020.36640 This study’s results suggest important differences in heroin treatment admissions to state-regulated programs by...

Source: Linas BP, Savinkina A, Madushani RWMA, et al. Projected Estimates of Opioid Mortality After Community-Level Interventions. JAMA Netw Open. 2021;4(2):e2037259. doi:10.1001/jamanetworkopen.2020.37259 Key Points Question Using simulated urban and rural communities, what evidence-based practices...

Fuente: https://store.samhsa.gov/sites/default/files/SAMHSA_Digital_Download/PEP20-05-02-003%20PDF_508.pdf Esta publicación presenta datos recientes sobre la prevalencia del uso indebido de opioides y las tasas de mortalidad en la población hispana / latina, los factores contextuales y los desafíos...

Source: Courser, M. W., & Raffle, H. (2021). With crisis comes opportunity: Unanticipated benefits resulting from pivots to take-home naloxone (THN) programs during the COVID-19 pandemic. Journal of Substance Abuse Treatment, 122, 108220. Highlights •It is important to consider the needs of people...

Source: Khan, A., Khan, Q., & Kolb, E. (2021). Supportive alternate site provision of buprenorphine: Overcoming barriers and improving patient outcomes. Journal of Substance Abuse Treatment, 123, 108256. Highlights •Provision of buprenorphine at scheduled clinic visits as opposed to filling...

Source: Figgatt, M. C., Salazar, Z., Day, E., Vincent, L., & Dasgupta, N. (2021). Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19. Journal of Substance Abuse Treatment, 123, 108276. Highlights •Methadone take-home dosing of survey participants...

Source: Xu KY, Presnall N, Mintz CM, et al. Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events. JAMA Netw Open. 2021;4(2):e210061. doi:10.1001/jamanetworkopen.2021.0061 Key Points Question Are opioid use disorder (OUD) medications associated with alcohol-related...

Source: Grella, C.E., Ostlie, E., Scott, C.K. et al. A scoping review of factors that influence opioid overdose prevention for justice-involved populations. Subst Abuse Treat Prev Policy 16, 19 (2021). https://doi.org/10.1186/s13011-021-00346-1 Abstract Background There is a high risk of death from...

Source: Mégarbane, B., Oberlin, M., Alvarez, JC. et al. Management of pharmaceutical and recreational drug poisoning. Ann. Intensive Care 10, 157 (2020). https://doi.org/10.1186/s13613-020-00762-9 Abstract Background Poisoning is one of the leading causes of admission to the emergency department and...

Source: dela Cruz, A.M., Walker, R., Pipes, R. et al. Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care. Addict Sci Clin Pract 16, 12 (2021). https://doi.org/10.1186/s13722-021-00222-0 Abstract Background The treatment...

Source: Puckett, H.M., Bossaller, J.S. & Sheets, L.R. The impact of project ECHO on physician preparedness to treat opioid use disorder: a systematic review. Addict Sci Clin Pract 16, 6 (2021). https://doi.org/10.1186/s13722-021-00215-z Abstract Opioid use disorder (OUD) is a medical condition that...

Fuente: Fleiz-Bautista, C., Domínguez-García, M., Villatoro-Velázquez, JA., Vázquez-Quiroz, F., Zafra-Mora, E., Sánchez-Ramos R., Resendiz-Escobar E., Bustos-Gamiño M., Medina-Mora ME. Cuqueando la Chiva: Contextos del consumo de heroína en la frontera norte de México… Ciudad de México, México...